Certificate in Pharma Health Economics: Cost-Effective Solutions
-- ViewingNowThe Certificate in Pharma Health Economics: Cost-Effective Solutions is a comprehensive course designed to equip learners with critical skills in pharmaceutical health economics. This program emphasizes the importance of cost-effective drug development and delivery, an increasingly vital aspect of the pharmaceutical industry.
5,979+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Introduction to Pharma Health Economics: Understanding the fundamental principles and concepts of health economics within the pharmaceutical industry. This unit will cover the basics of health economics, including the economic evaluation of pharmaceuticals and the role of health economics in pharmaceutical decision-making.
⢠Cost-Effectiveness Analysis (CEA): This unit will focus on the methods and techniques used in cost-effectiveness analysis, including the incremental cost-effectiveness ratio (ICER), quality-adjusted life years (QALYs), and sensitivity analysis.
⢠Budget Impact Analysis (BIA): In this unit, students will learn about the purpose, methods, and limitations of budget impact analysis, including the impact of pharmaceutical interventions on healthcare budgets.
⢠Pharmacoeconomics and Reimbursement Decisions: Students will explore the relationship between pharmacoeconomics and reimbursement decisions, including the role of health technology assessment (HTA) and the factors that influence reimbursement decisions.
⢠Real-World Data (RWD) and Real-World Evidence (RWE) in Pharmacoeconomics: This unit will cover the use of real-world data and real-world evidence in pharmacoeconomics, including the strengths and limitations of RWD/RWE and the role of RWD/RWE in pharmaceutical decision-making.
⢠Healthcare Systems and Pharmaceutical Markets: Students will learn about the different healthcare systems and pharmaceutical markets around the world, including the challenges and opportunities of each market.
⢠Pharmaceutical Pricing and Reimbursement Policies: This unit will explore the various pricing and reimbursement policies used in different healthcare systems, including the impact of these policies on patient access and pharmaceutical innovation.
⢠Pharmacoeconomic Modeling: Students will learn about the methods and techniques used in pharmacoeconomic modeling, including decision tree analysis, Markov modeling, and simulation modeling.
⢠Ethical Considerations in Pharma Health Economics: This unit will cover the ethical considerations involved in pharmacoeconomic analysis, including
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëŹ¸
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë
